Statehood for D.C. and Puerto Rico only needs 50 votes

And Democrats don't need to nuke the filibuster to do it

A flag.
(Image credit: Illustrated | iStock)

Many journalists and political commentators have been pessimistic about the possibility of statehood for the District of Columbia and Puerto Rico. This seems to be primarily because, despite the recent Democratic victories in Georgia, moderate senators like Joe Manchin (D-W.V.), Diane Feinstein (D-Calif), and Angus King (I-Maine) continue to support the legislative filibuster. It is impossible to imagine Republican senators voting to give Democratic-leaning areas full representation, so the issue must be dead on arrival in the upper chamber. But in a recent CNN interview, Manchin himself provided evidence for why this thinking is all wrong.

In the interview, Manchin reaffirmed his opposition to eliminating the legislative filibuster, but in response to a separate question about D.C. and Puerto Rico statehood, said that, "I don't know enough about that yet. I want to see the pros and cons. So, I'm waiting to see all the facts. I'm open up to see everything." What goes unsaid but implied is that these two answers are not incompatible. In fact, there is a solid legal, historic, and moral case that the legislative filibuster can remain but that it shouldn't be applied to statehood.

Subscribe to The Week

Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

SUBSCRIBE & SAVE
https://cdn.mos.cms.futurecdn.net/flexiimages/jacafc5zvs1692883516.jpg

Sign up for The Week's Free Newsletters

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.

Sign up
Jon Walker

Jon Walker is the author of After Legalization: Understanding the Future of Marijuana Policy. He is a freelance reporter and policy analyst that focuses on health care, drug policy, and politics.